Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study
BackgroundThe potential for hepatotoxicity during isoniazid-based tuberculosis (TB) treatment presents a major challenge for TB control programs worldwide. We sought to determine whether pharmacokinetic exposures of isoniazid and its metabolites were related to cellular oxidation/reduction status an...
Main Authors: | Isaac Zentner, Hyun-moon Back, Leonid Kagan, Selvakumar Subbian, Jyothi Nagajyothi, Shashikant Srivastava, Jotam Pasipanodya, Tawanda Gumbo, Gregory P. Bisson, Christopher Vinnard |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01103/full |
Similar Items
-
Clinical perspectives of isoniazid-induced liver injury
by: Saifei Lei, et al.
Published: (2021-06-01) -
Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China
by: Fengmin Huo, et al.
Published: (2019-08-01) -
In vitro anti-mycobacterial activity of (E)-N´-(monosubstituted-benzylidene) isonicotinohydrazide derivatives against isoniazid-resistant strains
by: Tatiane S. Coelho, et al.
Published: (2012-02-01) -
Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
by: Lingaraja Jena, et al.
Published: (2014-01-01) -
Acute psychosis secondary to isoniazid in pediatric pulmonary tuberculosis: A case report and literature review
by: Saleh Alfawaz, et al.
Published: (2020-12-01)